RLAY
NASDAQ HealthcareRelay Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $10.55 |
|---|---|
| Volume | 2,380,973 |
| Market Cap | 1.89B |
| Beta | 1.620 |
| RSI (14-Day) | 70.9 Overbought |
| 200-Day MA | $5.98 |
| 50-Day MA | $8.68 |
| 52-Week High | $11.43 |
| 52-Week Low | $1.77 |
| Forward P/E | -6.82 |
| Price / Book | 3.24 |
🎯 Investment Strategy Scores
How RLAY scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
11/100
High dividend yield + low volatility
🚀 Moon Shot
50/100
High growth potential (high beta + oversold)
🔪 Falling Knife
1/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
95/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
39/100
Large-cap, institutional-quality stocks
Find RLAY in your text
Paste any text on the homepage — the tool will extract RLAY and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.